<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//TaxonX//DTD Taxonomic Treatment Publishing DTD v0 20100105//EN" "../../nlm/tax-treatment-NS0.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:tp="http://www.plazi.org/taxpub" article-type="research-article" dtd-version="3.0" xml:lang="en">
  <front>
    <journal-meta>
      <journal-id journal-id-type="publisher-id">87</journal-id>
      <journal-id journal-id-type="index">urn:lsid:arphahub.com:pub:A116C711-4C18-5A38-8F1E-5E97753A8A64</journal-id>
      <journal-title-group>
        <journal-title xml:lang="en">Folia Medica</journal-title>
        <abbrev-journal-title xml:lang="en">FM</abbrev-journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0204-8043</issn>
      <issn pub-type="epub">1314-2143</issn>
      <publisher>
        <publisher-name>Plovdiv Medical University</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="doi">10.3897/folmed.67.e141989</article-id>
      <article-id pub-id-type="publisher-id">141989</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Case Report</subject>
        </subj-group>
        <subj-group subj-group-type="scientific_subject">
          <subject>Emergency medicine</subject>
          <subject>Surgery &amp; Invasive treatment</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Endovascular repair of symptomatic fistulized pancreatic pseudocyst to superior mesenteric artery</article-title>
      </title-group>
      <contrib-group content-type="authors">
        <contrib contrib-type="author" corresp="yes">
          <name name-style="western">
            <surname>Tigkiropoulos</surname>
            <given-names>Konstantinos</given-names>
          </name>
          <email xlink:type="simple">kostastig@yahoo.com</email>
          <uri content-type="orcid">https://orcid.org/0000-0003-2183-7160</uri>
          <xref ref-type="aff" rid="A1">1</xref>
        </contrib>
        <contrib contrib-type="author" corresp="no">
          <name name-style="western">
            <surname>Sidiropoulou</surname>
            <given-names>Katerina</given-names>
          </name>
          <xref ref-type="aff" rid="A1">1</xref>
        </contrib>
        <contrib contrib-type="author" corresp="no">
          <name name-style="western">
            <surname>Chatziantoniou</surname>
            <given-names>Georgios</given-names>
          </name>
          <xref ref-type="aff" rid="A1">1</xref>
        </contrib>
        <contrib contrib-type="author" corresp="no">
          <name name-style="western">
            <surname>Karamanos</surname>
            <given-names>Dimitrios</given-names>
          </name>
          <xref ref-type="aff" rid="A1">1</xref>
        </contrib>
        <contrib contrib-type="author" corresp="no">
          <name name-style="western">
            <surname>Saratzis</surname>
            <given-names>Nikolaos</given-names>
          </name>
          <xref ref-type="aff" rid="A1">1</xref>
        </contrib>
      </contrib-group>
      <aff id="A1">
        <label>1</label>
        <addr-line content-type="verbatim">Division of Vascular Surgery, First Surgical Department, School of Medicine, Aristotle University, Papageorgiou General Hospital, Thessaloniki, Greece</addr-line>
        <institution>Aristotle University</institution>
        <addr-line content-type="city">Thessaloniki</addr-line>
        <country>Greece</country>
      </aff>
      <author-notes>
        <fn fn-type="corresp">
          <p>Corresponding author: Konstantinos Tigkiropoulos, Division of Vascular Surgery, First Surgical Department, School of Medicine, Aristotle University, Papageorgiou General Hospital, Poseidonos 17A, 56429 Thessaloniki, Greece; Email: <email xlink:type="simple">kostastig@yahoo.com</email>; Tel.:+306944173723</p>
        </fn>
      </author-notes>
      <pub-date pub-type="collection">
        <year>2025</year>
      </pub-date>
      <pub-date pub-type="epub">
        <day>16</day>
        <month>05</month>
        <year>2025</year>
      </pub-date>
      <volume>67</volume>
      <issue>3</issue>
      <elocation-id>e141989</elocation-id>
      <uri content-type="arpha" xlink:href="http://openbiodiv.net/5E810E08-9434-58B6-8CDD-AA029AC27B25">5E810E08-9434-58B6-8CDD-AA029AC27B25</uri>
      <history>
        <date date-type="received">
          <day>17</day>
          <month>11</month>
          <year>2024</year>
        </date>
        <date date-type="accepted">
          <day>07</day>
          <month>12</month>
          <year>2024</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>Konstantinos Tigkiropoulos, Katerina Sidiropoulou, Georgios Chatziantoniou, Dimitrios Karamanos, Nikolaos Saratzis</copyright-statement>
        <license license-type="creative-commons-attribution" xlink:href="http://creativecommons.org/licenses/by/4.0/" xlink:type="simple">
          <license-p>This is an open access article distributed under the terms of the Creative Commons Attribution License (CC BY 4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p>
        </license>
      </permissions>
      <abstract>
        <label>Abstract</label>
        <p>Pancreatic pseudocysts are considered a common complication of chronic pancreatitis. They can be infected, resulting in abscess formation; erode the wall of surrounding vascular structures, resulting in communication with them, leading to hemorrhage through the gastrointestinal tract; or rupture in the peritoneum with catastrophic consequences. Endovascular repair is a minimally invasive technique that permits exclusion of communication between pancreatic pseudocysts and vessels with low perioperative morbidity and mortality. We present a case of a symptomatic male patient with a hemorrhagic pancreatic pseudocyst due to a fistula with the superior mesenteric artery successfully managed endovascularly by deployment of a stent graft.</p>
      </abstract>
      <kwd-group>
        <label>Keywords</label>
        <kwd>chronic pancreatitis</kwd>
        <kwd>complications</kwd>
        <kwd>fistula</kwd>
        <kwd>stent graft</kwd>
      </kwd-group>
    </article-meta>
    <notes>
      <sec sec-type="Citation" id="SECID0E3D">
        <title>Citation</title>
        <p>Tigkiropoulos K, Sidiropoulou K, Chatziantoniou G, Karamanos D, Saratzis N. Endovascular repair of symptomatic fistulized pancreatic pseudocyst to superior mesenteric artery. Folia Med (Plovdiv) 2025;67(3):e141989. doi: <ext-link xlink:type="simple" ext-link-type="doi" xlink:href="10.3897/folmed.67.e141989">10.3897/folmed.67.e141989</ext-link>.</p>
      </sec>
    </notes>
  </front>
  <body>
    <sec sec-type="Introduction" id="SECID0EIE">
      <title>Introduction</title>
      <p>Chronic pancreatitis is a multifactorial inflammatory syndrome in which repetitive episodes of pancreatic inflammation lead to exocrine and endocrine insufficiency. Pancreatic pseudocysts are considered one of the major complications of pancreatitis. Most of them are resolved spontaneously; however, if they produce symptoms like pain and jaundice or increase in size after 6 weeks, endoscopic or surgical management may be necessary to avoid complications.<sup>[<xref ref-type="bibr" rid="B1">1</xref>,<xref ref-type="bibr" rid="B2">2</xref>]</sup> Hemorrhage is considered one of the most life-threatening complications of pseudocysts, with a reported incidence of 6%–17% and mortality of 12%–40%.<sup>[<xref ref-type="bibr" rid="B3 B4 B5 B6 B7">3–7</xref>]</sup> They can fistulize to surrounding vessels, most frequently to splenic artery, gastroduodenal artery, portal vein, splenic vein, and superior mesenteric vein.<sup>[<xref ref-type="bibr" rid="B8 B9 B10">8–10</xref>]</sup> Fistulization of superior mesenteric artery with a pancreatic pseudocyst is a rare entity with only two cases described in the literature.<sup>[<xref ref-type="bibr" rid="B11">11</xref>,<xref ref-type="bibr" rid="B12">12</xref>]</sup> Nowadays, endovascular techniques (embolization with coils/glue, stent graft) are considered an efficacious treatment modality for such communications with low perioperative morbidity and mortality and high technical success rate.<sup>[<xref ref-type="bibr" rid="B12">12</xref>,<xref ref-type="bibr" rid="B13">13</xref>]</sup> We report the case of a symptomatic male patient with hemorrhagic pseudocyst due to the presence of a fistula with superior mesenteric artery successfully managed endovascularly with stent graft deployment.</p>
    </sec>
    <sec sec-type="Case report" id="SECID0ERF">
      <title>Case report</title>
      <p><italic>A 47-year-old Caucasian male patient presented at the emergency room of a peripheral hospital with abdominal pain for the last 24 hours. His medical history was remarkable for daily alcohol consumption for at least 10 years, recurrent episodes of alcohol-induced pancreatitis in the last 2 years, coronary artery disease that was managed by percutaneous coronary angioplasty in 2019, arterial hypertension, dyslipidemia, and current smoking. His medication was clopidogrel, statin, and ß-blocker. On clinical examination, the patient was hemodynamically stable, and the electrocardiography showed sinus rhythm. He suffered from abdominal pain located in the epigastrium with tenderness at deep palpation without peritonism radiating to the lumbar region. His bowel sounds were not pathological, and the digital rectal examination was negative for blood. Laboratory tests revealed normal levels of white blood cell count, hemoglobin, serum, and urine amylase but a slight increase of hepatic enzymes (SGOT 54 U/L, normal range 11-34 U/L) (SGPT 71 U/L, normal range 0-45 U/L)</italic><bold><italic>(Table <xref ref-type="table" rid="T1">1</xref>)</italic></bold> . <italic>The pain did not subside with intravenous administration of paracetamol, and a contrast-enhanced computed tomography (<abbrev xlink:title="computed tomography" id="ABBRID0EDG">CT</abbrev>) was decided. The <abbrev xlink:title="computed tomography" id="ABBRID0EHG">CT</abbrev> depicted parenchymal pancreatic calcification due to chronic pancreatitis, a round 50 mm mass behind the pancreatic head and uncinate process that was in contact with the superior mesenteric artery (<abbrev xlink:title="superior mesenteric artery" id="ABBRID0ELG">SMA</abbrev>) and deviated it to the left.</italic><bold><italic>(Fig. <xref ref-type="fig" rid="F1">1</xref>)</italic></bold> . <italic>The content of the sac was heterogeneous with hemorrhagic fluid signal intensity within. At the delayed phase of <abbrev xlink:title="computed tomography" id="ABBRID0E1G">CT</abbrev>, a communication between <abbrev xlink:title="superior mesenteric artery" id="ABBRID0E5G">SMA</abbrev> and the pseudocyst was noted with the presence of contrast agent within the pancreatic lesion</italic><bold><italic>(Fig. <xref ref-type="fig" rid="F2">2</xref>)</italic></bold> . <italic>The patient was transferred to our tertiary institution for further evaluation and treatment. After consultation with the general surgeons of our hospital, an endovascular repair of the fistulized pseudocyst with <abbrev xlink:title="superior mesenteric artery" id="ABBRID0ENH">SMA</abbrev> was decided since it was technically feasible. The mainstem of <abbrev xlink:title="superior mesenteric artery" id="ABBRID0ERH">SMA</abbrev> was 70 mm long, the diameter was 9 mm in the proximal part and 7 mm in the distal part at the level of the fistula without any other anomaly of arterial wall. The patient was informed perioperatively for all possible adverse events and a written informed consent was obtained for endovascular repair. Operation was performed in a fully equipped operation theatre with a portable C-arm (Ziehm Vision RFD, Hybrid Edition, Nuremberg, Germany). Under general anesthesia, arterial access was gained through surgical cut down of the left brachial artery. After systemic heparinization (75 IU/kg), a 5Fr sheath was placed. A hydrophilic guidewire 0.035 inches (Radifocus, Terumo Corp, Tokyo, Japan) was advanced to the abdominal aorta. The 5Fr sheath was exchanged with a 7Fr 90-cm long sheath. An aortic angiography was performed which revealed the <abbrev xlink:title="superior mesenteric artery" id="ABBRID0EVH">SMA</abbrev> orifice. <abbrev xlink:title="superior mesenteric artery" id="ABBRID0EZH">SMA</abbrev> was successfully catheterized with a 100 cm long Bern catheter (Boston Scientific, Marlborough, USA) and Terumo guidewire was exchanged with a Rosenwire 260 cm long (Cook Medical, Bloomington, USA) to avoid any injury to <abbrev xlink:title="superior mesenteric artery" id="ABBRID0E4H">SMA</abbrev> and its branches. Two balloon expandable stent grafts ICover (IVascular, Barcelona, Spain) 8×37 mm and 9×37 mm were deployed distally to proximally in the <abbrev xlink:title="superior mesenteric artery" id="ABBRID0ECAAC">SMA</abbrev> to counteract size discrepancy of the artery</italic><bold><italic>(Fig. <xref ref-type="fig" rid="F3">3</xref>)</italic></bold> . <italic>Total operation time was 62 minutes and the contrast amount was 80 ml. Postoperative period was uneventful, abdominal pain subsided and the patient was discharged on the fifth postoperative day under dual antiplatelet therapy for at least 3 months followed by a lifelong single antiplatelet regimen. Follow-up <abbrev xlink:title="computed tomography" id="ABBRID0ERAAC">CT</abbrev> at 1 month revealed patent <abbrev xlink:title="superior mesenteric artery" id="ABBRID0EVAAC">SMA</abbrev> covered stent with absence of communication and shrinkage of the pancreatic pseudocyst to 15 mm</italic><bold><italic>(Fig. <xref ref-type="fig" rid="F4">4</xref>)</italic></bold> .</p>
      <table-wrap id="T1" position="float" orientation="portrait">
        <label>Table 1.</label>
        <caption>
          <p>Laboratory preoperative tests of the patient</p>
        </caption>
        <table id="TID0EALAC" rules="all">
          <tbody>
            <tr>
              <td rowspan="1" colspan="2">
                <bold>Parameter</bold>
              </td>
              <td rowspan="1" colspan="1">
                <bold>Normal range</bold>
              </td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">White blood cells</td>
              <td rowspan="1" colspan="1">9.4 K/pl</td>
              <td rowspan="1" colspan="1">3.7–9.5 K/pl</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">Red blood cells</td>
              <td rowspan="1" colspan="1">4.34 M/pL</td>
              <td rowspan="1" colspan="1">4.3–5.6 M/pl</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">Hemoglobin</td>
              <td rowspan="1" colspan="1">14.9 g/dl</td>
              <td rowspan="1" colspan="1">13–17 g/dl</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">Platelets</td>
              <td rowspan="1" colspan="1">162 K/pl</td>
              <td rowspan="1" colspan="1">150–400 K/pl</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">SGOT</td>
              <td rowspan="1" colspan="1">54 U/L</td>
              <td rowspan="1" colspan="1">11–34 U/L</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">SGPT</td>
              <td rowspan="1" colspan="1">71 U/L</td>
              <td rowspan="1" colspan="1">0–45 U/L</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">Serum amylase</td>
              <td rowspan="1" colspan="1">191 U/L</td>
              <td rowspan="1" colspan="1">28–100 U/L</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">Urine α-amylase</td>
              <td rowspan="1" colspan="1">404 U/l</td>
              <td rowspan="1" colspan="1">16–491 U/l</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">Glucose</td>
              <td rowspan="1" colspan="1">105 mg/dl</td>
              <td rowspan="1" colspan="1">70–105 mg/dl</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">Creatinine</td>
              <td rowspan="1" colspan="1">0.61 mg/dl</td>
              <td rowspan="1" colspan="1">0.72–1.25 mg/dl</td>
            </tr>
          </tbody>
        </table>
      </table-wrap>
      <fig id="F1" position="float" orientation="portrait">
        <object-id content-type="arpha">BADBDA3B-8097-5E86-88CC-FA39DDA4D2BF</object-id>
        <label>Figure 1.</label>
        <caption>
          <p>Contrast-enhanced computed tomography (<abbrev xlink:title="computed tomography" id="ABBRID0EHFAC">CT</abbrev>) depicted a 50 mm mass (small arrow) behind the head of the pancreas which deviates superior mesenteric artery (long arrow) to the left.</p>
        </caption>
        <graphic xlink:href="foliamedica-67-3-e141989-g001.jpg" position="float" orientation="portrait" xlink:type="simple" id="oo_1329652.jpg">
          <uri content-type="original_file">https://binary.pensoft.net/fig/1329652</uri>
        </graphic>
      </fig>
      <fig id="F2" position="float" orientation="portrait">
        <object-id content-type="arpha">B88ED5FB-F5DE-5DA2-846B-37CC7A86291C</object-id>
        <label>Figure 2.</label>
        <caption>
          <p><abbrev xlink:title="computed tomography" id="ABBRID0EYFAC">CT</abbrev> at delayed arterial phase showed extravasation of contrast agent within the pseudocyst confirming the presence of a fistula (black arrow).</p>
        </caption>
        <graphic xlink:href="foliamedica-67-3-e141989-g002.jpg" position="float" orientation="portrait" xlink:type="simple" id="oo_1329653.jpg">
          <uri content-type="original_file">https://binary.pensoft.net/fig/1329653</uri>
        </graphic>
      </fig>
      <fig id="F3" position="float" orientation="portrait">
        <object-id content-type="arpha">21AF353F-C1C3-5E34-842D-491D661A6604</object-id>
        <label>Figure 3.</label>
        <caption>
          <p>Intraoperative angiography after deployment of covered stents at distal part of superior mesenteric artery with patency of peripheral branches.</p>
        </caption>
        <graphic xlink:href="foliamedica-67-3-e141989-g003.jpg" position="float" orientation="portrait" xlink:type="simple" id="oo_1329654.jpg">
          <uri content-type="original_file">https://binary.pensoft.net/fig/1329654</uri>
        </graphic>
      </fig>
      <fig id="F4" position="float" orientation="portrait">
        <object-id content-type="arpha">45838B14-D160-515D-A449-A67EFA6B05A1</object-id>
        <label>Figure 4.</label>
        <caption>
          <p><abbrev xlink:title="computed tomography" id="ABBRID0EVGAC">CT</abbrev> follow-up at 1 month depicted shrinkage of the pseudocyst (small black arrow) and excellent patency of covered stents at superior mesenteric artery (long black arrow).</p>
        </caption>
        <graphic xlink:href="foliamedica-67-3-e141989-g004.jpg" position="float" orientation="portrait" xlink:type="simple" id="oo_1329655.jpg">
          <uri content-type="original_file">https://binary.pensoft.net/fig/1329655</uri>
        </graphic>
      </fig>
    </sec>
    <sec sec-type="Discussion" id="SECID0E5GAC">
      <title>Discussion</title>
      <p>Patients with chronic pancreatitis may suffer from arterial complications such as arterial thrombosis from local compression of an artery from a pancreatic pseudocyst, arterial bleeding during percutaneous drainage of pseudocyst as well as arterial pseudoaneurysms.<sup>[<xref ref-type="bibr" rid="B14">14</xref>]</sup> Fistulization of a pancreatic pseudocyst is a rare, life-threatening complication. If communication exists with surrounding vessels, pseudoaneurysm or hemorrhage within the pseudocyst can occur.‌<sup>[<xref ref-type="bibr" rid="B12">12</xref>]</sup> Its incidence is low in patients with chronic pancreatitis; however, it is associated with high mortality.<sup>[<xref ref-type="bibr" rid="B7">7</xref>,<xref ref-type="bibr" rid="B14">14</xref>]</sup> In a meta-analysis of 29 studies, the pooled incidence rate of pseudoaneurysms in chronic pancreatitis was 0.03%.<sup>[<xref ref-type="bibr" rid="B13">13</xref>]</sup> In a retrospective analysis by Anand et al., pseudocyst and alcoholic pancreatitis were independent factors for pseudoaneurysm formation.<sup>[<xref ref-type="bibr" rid="B15">15</xref>]</sup> The main pathophysiological mechanism is the proteolytic action of pancreatic enzymes in surrounding vessels resulting in vessel wall erosion and loss of their integrity.<sup>[<xref ref-type="bibr" rid="B14">14</xref>]</sup> The splenic artery, gastroduodenal artery, and superior-inferior pancreaticoduodenal arteries are the most frequently involved with pancreatic pseudocysts.<sup>[<xref ref-type="bibr" rid="B8">8</xref>,<xref ref-type="bibr" rid="B10">10</xref>]</sup> Fistulization of a pancreatic pseudocyst with <abbrev xlink:title="superior mesenteric artery" id="ABBRID0EVIAC">SMA</abbrev> has been reported in only 2 cases in the literature. Bouassida et al. reported a patient presented with gastrointestinal bleeding due to erosion of a pancreatic pseudocyst in <abbrev xlink:title="superior mesenteric artery" id="ABBRID0EZIAC">SMA</abbrev> with fatal outcome<sup>[<xref ref-type="bibr" rid="B12">12</xref>]</sup>, whereas Cowan et al. reported the first successful endovascular management of <abbrev xlink:title="superior mesenteric artery" id="ABBRID0EEJAC">SMA</abbrev> pseudoaneurysm fistulized to pancreatic pseudocyst with deployment of polytetrafluoroethylene stent graft.<sup>[<xref ref-type="bibr" rid="B11">11</xref>]</sup> If deployment of a stent-graft is not feasible due to technical and anatomical issues in the presence of pseudoaneurysm, endovascular embolization is an alternative minimal invasive technique. Its efficacy has been demonstrated in a meta-analysis where the pooled technical success rate was 97% and clinical success rates at ≤3 months, 3-12 months, and &gt;12 months were 82%, 86%, and 88%, respectively.<sup>[<xref ref-type="bibr" rid="B14">14</xref>]</sup> Additionally, endoscopic ultrasound-guided endovascular therapy is a novel, minimally invasive tool for the management of gastrointestinal bleeding that involves the placement of thrombotic materials or coils in the targeted vessels, representing a new area of development with limited results.</p>
    </sec>
    <sec sec-type="Conclusion" id="SECID0EWJAC">
      <title>Conclusion</title>
      <p>Fistulization of pancreatic pseudocyst with the superior mesenteric artery is a rare entity that, if left untreated, can lead to devastating consequences. The diagnosis is often delayed due to its infrequent occurrence and clinical presentation. Imaging with computed tomography angiography can diagnose hemorrhagic complications of pseudocysts. Regarding therapeutic strategies, endovascular repair, whenever it is feasible as a minimally invasive technique with its armamentarium (embolization, stent graft), can manage such pathologies with low perioperative morbidity and mortality.</p>
    </sec>
    <sec sec-type="Ethical clearance" id="SECID0E2JAC">
      <title>Ethical clearance</title>
      <p>Written informed consent was provided by the patient.</p>
    </sec>
    <sec sec-type="Conflict of interest" id="SECID0EAKAC">
      <title>Conflict of interest</title>
      <p>The authors have no conflicts of interest to declare.</p>
    </sec>
    <sec sec-type="Financial disclosure" id="SECID0EFKAC">
      <title>Financial disclosure</title>
      <p>The authors declare that this study has received no financial support.</p>
    </sec>
    <sec sec-type="Author contributions" id="SECID0EKKAC">
      <title>Author contributions</title>
      <p>K.T., K.S., and G.C.: primary idea, writing, literature review. D.K. and N.S.: supervision</p>
    </sec>
  </body>
  <back>
    <ref-list>
      <title>References</title>
      <ref id="B1">
        <mixed-citation xlink:type="simple">1. Sedik A, Touheria M, Fathi A, et al. Spontaneous rupture of the pancreatic pseudocyst into the duodenum with massive upper gastrointestinal bleeding: case report and literature review. Int Surg J 2020; 7:3792–94.</mixed-citation>
      </ref>
      <ref id="B2">
        <mixed-citation xlink:type="simple">2. Mullins RJ, Malagoni MA, Bergamini TM, et al. Controversies in the management of pancreatic pseudocysts. Am J Surg 1998; 155:165–72.</mixed-citation>
      </ref>
      <ref id="B3">
        <mixed-citation xlink:type="simple">3. Sankaran S, Walt S. The natural and unnatural history of pancreatic pseudocysts. Br J Surg 1975; 62:37–9.</mixed-citation>
      </ref>
      <ref id="B4">
        <mixed-citation xlink:type="simple">4. Kiviluoto T, Kivisaari L, Kivilaakso E. Pseudocysts in chronic pancreatitis: surgical results in 102 consecutive patients. Arch Surg 1989; 124:240–3.</mixed-citation>
      </ref>
      <ref id="B5">
        <mixed-citation xlink:type="simple">5. El Hamel A, Parc R, Adda G, et al. Bleeding pseudocysts and pseudoaneurysms in chronic pancreatitis. Br J Surg 1991; 78:1059–63.</mixed-citation>
      </ref>
      <ref id="B6">
        <mixed-citation xlink:type="simple">6. Stanley JC, Frey CF, Miller TA. Major arterial hemorrhage: a complication of pancreatic pseudocysts and chronic pancreatitis. Arch Surg 1976; 111:435–40.</mixed-citation>
      </ref>
      <ref id="B7">
        <mixed-citation xlink:type="simple">7. Gadacz TR, Kieffer RF, Trunkey D. Visceral vessel erosion associated with pancreatitis. Arch Surg 1978; 113:1438–40.</mixed-citation>
      </ref>
      <ref id="B8">
        <mixed-citation xlink:type="simple">8. Carr JA, Cho JS, Shepard AD, et al. Visceral pseudoaneurysms due to pancreatic pseudocysts: Rare but lethal complications of pancreatitis. J Vasc Surg 2000; 32:722–30.</mixed-citation>
      </ref>
      <ref id="B9">
        <mixed-citation xlink:type="simple">9. Makary MS, Gayou EL, Kyrouac D, et al. Pancreaticoportal fistula formation as a consequence of recurrent acute pancreatitis: clinical and imaging considerations. J Clin Imaging Sci 2018; 8:4.</mixed-citation>
      </ref>
      <ref id="B10">
        <mixed-citation xlink:type="simple">10. Denys A, Hammel P, De Baere T, et al. Arterioportal fistula due to a ruptured pancreatic pseudocyst: diagnosis and endovascular treatment. Am J Roentgenol 1998; 170:1205–6.</mixed-citation>
      </ref>
      <ref id="B11">
        <mixed-citation xlink:type="simple">11. Cowan S, Kahn MB, Bonn J, et al. Superior mesenteric artery pseudoaneurysm successfully treated with polytetrafluoroethylene covered stent. J Vasc Surg 2002; 35:805–7.</mixed-citation>
      </ref>
      <ref id="B12">
        <mixed-citation xlink:type="simple">12. Bouassida M, Benali M, Charrada H, et al. Gastrointestinal bleeding due to an erosion of the superior mesenteric artery: an exceptional fatal complication of pancreatic pseudocyst. Pan Afr Med 2012: 12:62.</mixed-citation>
      </ref>
      <ref id="B13">
        <mixed-citation xlink:type="simple">13. Sagar S, Soundarajan R, Gupta P, et al. Efficacy of endovascular embolization of arterial pseudoaneurysms in pancreatitis: A systematic review and meta-analysis. Pancreatology 2021; 21:46–58.</mixed-citation>
      </ref>
      <ref id="B14">
        <mixed-citation xlink:type="simple">14. Walia D, Saraya A, Gunjan D. Vascular complications of chronic pancreatitis and its management. World J Gastrointest Surg 2023; 15:1574–90.</mixed-citation>
      </ref>
      <ref id="B15">
        <mixed-citation xlink:type="simple">15. Anand A, Gunjan D, Agarwal S, et al. Vascular complications of chronic pancreatitis: A tertiary center experience. Pancreatology 2020; 20:1085–91.</mixed-citation>
      </ref>
    </ref-list>
  </back>
</article>
